← Back to Screener
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)
Price$10.64
Favorite Metrics
Price vs S&P 500 (26W)0.15%
Price vs S&P 500 (4W)-3.02%
Market Capitalization$261.81M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)1.51%
10-Day Avg Trading Volume0.06M
Quick Ratio (Quarterly)1.09x
3-Month Avg Trading Volume0.05M
52-Week High$10.74
26-Week Price Return2.31%
13-Week Price Return0.85%
Current Ratio (Quarterly)1.09x
3-Month Return Std Dev5.93%
Year-to-Date Return0.66%
5-Day Price Return0.57%
Month-to-Date Return0.66%
Price vs S&P 500 (13W)1.35%
Beta0.10x
52-Week Low$10.04
Industry Peers — Blank Checks / SPACs(332)
| Symbol | P/E Ratio (Annual) | Indicated Dividend Yield (Annual) | ROE (TTM) | P/B Ratio (Quarterly) | Price |
|---|---|---|---|---|---|
OACCOaktree Acquisition Corp. III Life Sciences Class A Ordinary Share | — | — | — | — | $10.64 |
LFACLeapfrog Acquisition Corporation Class A Ordinary Shares | 742.60x | — | 1.92% | 2.80x | $9.92 |
LFACULeapfrog Acquisition Corporation Units | 742.60x | — | 1.92% | 2.80x | $10.04 |
AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | -9.52% | 14.61x | $9.88 |
BEAGRBold Eagle Acquisition Corp. Right | 62.09x | — | 3.80% | 2.33x | $0.24 |
BEAGUBold Eagle Acquisition Corp. Units | 62.09x | — | 3.80% | 2.33x | $10.77 |
BEAGBold Eagle Acquisition Corp. Class A Ordinary Shares | 61.91x | — | 3.80% | 2.33x | $10.55 |
BCSSBain Capital GSS Investment Corp. | 138.75x | — | — | 1.31x | $10.13 |
BCSS.UBain Capital GSS Investment Corp. Units, each consisting of one Class A Ordinary Share and one-fifth of one redeemable warrant | 138.75x | — | — | 1.31x | $10.24 |
CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | 95.53x | — | — | 1.29x | $10.21 |
BACQRInflection Point Acquisition Corp. IV Right | 80.29x | — | 2.41% | 1.41x | $0.74 |
About
Oaktree Acquisition Corp III Life Sciences is a special purpose acquisition company (SPAC) established to identify, acquire, and operate a business in the life sciences sector. The blank-check company was formed to raise capital through a public offering for the purpose of merging with or acquiring an operating company in life sciences.